Welcome to the Journal of Medical Chemical, Biological and Radiological Defense

           The Journal of Medical Chemical, Biological, & Radiological Defense (J Med CBR Defense) is a peer-reviewed scientific online journal that meets the demands for information on the biology, chemistry, physiology, toxicology and treatment of exposure to chemical, biological and radiological threat agents. J Med CBR Defense provides a single international forum for the publication of current research and development information on medical chemical, biological and radiological defense, as well as training, doctrine, and problems related to chemical, biological and radiological casualties.

           The Journal also hosts an archive of related papers from authors in the field. Although articles will be published on the web continuously, there will be quarterly issues. The J Med CBR Defense is published electronically and is made available to the scientific community free of charge.
All submissions are reviewed by an editorial board composed of well-known and respected international scientists who represent different aspects of medical chemical, biological and radiological defense. J Med CBR Defense is committed to providing its readers with quality scientific information and critical analyses.

           Contributions submitted to J Med CBR Defense must be original works of the author(s) that have not been previously published or simultaneously submitted to other publications. The author(s) must transfer the copyright of articles published in J Med CBR Defense to the journal. A copyright transfer form must accompany each manuscript submission. For more information on submitting to J Med CBR Defense, see the Authors' Guide.

ACKNOWLEDGMENT

           The Journal of Medical Chemical, Biological, & Radiological Defense gratefully acknowledges the continuing financial support for the journal and the scientific and editorial contributions provided by the Defense Threat Reduction Agency, Chemical & Biological Technologies Directorate.

MISSION:

           The mission of The Journal of Medical Chemical, Biological, & Radiological Defense is to provide an international, peer-reviewed journal of original scientific research and clinical and doctrinal knowledge in the area of medical chemical, biological and radiological defense; and to develop and maintain an archive of current research and development information on training, doctrine, and professional discussions of problems related to chemical, biological and radiological casualties.

           Areas of research include, but are not limited to, the following:

  • Neuroprotectants
  • Bioscavengers for Nerve Agents
  • Medical Diagnostic Systems and Technologies
  • Medical Effects of Low Level Exposures
  • Broad Spectrum Medical Countermeasures
  • Pretreatments and Therapeutics for Bacterial, Viral and Toxin Agents
  • Radiological Medical Countermeasures
  • Clinical Treatment of Chemical, Biological or Radiological Casualties

CONTENTS:

VOLUME 3 | 2005 - 2006

ANNOUNCEMENTS

The next deadline for submission of articles for consideration for inclusion in J Med CBR Defense is February 15, 2007. Articles may be submitted at any time and are published continuously on the website, but there are quarterly issues. See the ÒAuthorÕs GuideÓ section of the website for more information.
The Journal is also accepting recommendations and technical reports for incorporation into the archives. Such reports and proceedings need to be clear of copyrights. For questions about including such reports, please contact: editor@jmedcbr.org
If you have further announcements, please send them to: editor@jmedcbr.org

RESEARCH ARTICLES

Volume 4

  • Comparative Toxicity Studies Of Sulfur Mustard (2,2'-Dichloro Diethyl Sulfide) And Monofunctional Sulfur Mustard (2-Chloroethyl Ethyl Sulfide), Administered Through Various Routes In Mice; R. Vijayaraghavan, Anshoo Gautam, Manoj Sharma and K. Ganesan [5 Feb 2006]

Volume 3

  • Evaluation of Delayed Toxic Effects of Sulfur Mustard Poisoning in Severely Intoxicated Iranian Veterans: A Cross-Sectional Study; Mahdi Balali-Mood, Mehrdad Hefazi, Mahmoud Mahmoudi, Ishagh Jalali, Davoud Attaran, Masoud Maleki, Mohammad-Reza Etezad Razavi, Gholamali Zare, Mahmoud-Reza Jaafari, Abbas Tabatabaee [29 Apr 2005]
  • Dimethyl Sulfoxide Accelerates Mustard Gas-Induced Skin Pathology; John P. Petrali, Tracey A. Hamilton, Betty J. Benton, Dana R. Anderson, Wesley Holmes, Robert K. Kan, Christina P. Tompkins and Radharaman Ray [29 Apr 2005]
  • A Model for Prediction of Probability of Developing an Adverse Physiological Symptom in Individuals Percutaneously Exposed to VX Nerve Agent; Eva F. Gudgin Dickson, E.J. Scott Duncan, Paul D. Fedele, Doug Nelson [1 Jul 2005]
  • Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity; Oksana Lockridge, Lawrence M. Schopfer, Gail Winger, James H. Woods [1 Jul 2005]
  • Industrial Hazards to Military Personnel; D.P. Bacon, R.M. Garrett, P.L. Liotta, D.E. Mays, T.E. Miller [7 Jul Ô05]
  • Application of NMR and EPR Spectroscopy to the Analysis of the Reaction of Phosphovanadomolybdate Polyoxometalate (H5PV2Mo10O40) with Chloroethyl Sulfides (Half-Sulfur Mustard and Sulfur Mustard); Carmen M. Arroyo; James M. Sankovich | Damon L. Burman | David W. Kahler | Sunil-Datta Soni | Brennie E. Hackley Jr. [20 Sept 2005]
  • Neuroprotection for Nerve Agent-Induced Brain Damage by Blocking Delayed Calcium Overload: A Review; Margaret Filbert, Eric Levine, and Gerald Ballough [23 Nov 2005]
  • A Complex Process of the Development of New Acetylcholinesterase Reactivators - From Prediction to in Vivo Evaluation; J. Kassa, K. Kuca, J. Cabal, D. Jun, L. Bartosova, G. Kunesova, and V. Dohnal [7 Dec 2005]

RESEARCH NOTES

  • Neuropathological Assessment in Acute Neurotoxic States. The "Dark" Neuron; Bernard S. Jortner [1 Apr 2005]

POLICY, DOCTRINE AND OPERATIONAL ANALYSIS CLINICAL ARTICLES

  • Improvement of respiratory symptoms by long-term low-dose erythromycin in sulfur mustard exposed cases: A Pilot Study; Mostafa Ghanei, Mehdi Ghasem Zadeh, Majid Shohrati [7 Jul 2005]

CRITICAL REVIEWS

  • Ricin-Induced Tissue Toxicity: The Role of Oxidative Stress; Zacharias E. Suntres, William L. Stone, and Milton G. Smith [23 Dec 2005]

ARCHIVES OF RELATED LITERATURE

CORRESPONDENCE

LETTERS

ERRATA AND CORRECTIONS


For the Professional in Government and Industry with an interest in Nuclear, Biological and Chemical Defense, Disarmament and Verification; Emergency and Disaster Medical Planning; Industrial Health and Safety; and Environmental Protection


copyright©2006, ASA Inc. All rights reserved.